VASC Insider Trading Activity and SEC Form 4 Filings
VASC insider trading summary
No open-market insider purchases or sales of Vascular Solutions Inc (VASC) have been reported on SEC Form 4 in the past 12 months.
Latest VASC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 22, 2016 | Chad Kugler | Sr. VP of R&D | Sell | $103K (1,849 @ $55.70) |
| Jul 27, 2016 | Howard Root | Chief Executive Officer | Sell | $1.8M (40,000 @ $45.11) |
| Jul 27, 2016 | William Rutstein | Sr. VP of International Sales | Sell | $463K (10,011 @ $46.26) |
| May 24, 2016 | Howard Root | Chief Executive Officer | Sell | $1.3M (34,418 @ $39.05) |
| May 13, 2016 | Martin J Emerson | Director | Sell | $759K (20,000 @ $37.93) |
| May 13, 2016 | James Hennen | Sr. VP of Finance and CFO | Sell | $449K (11,785 @ $38.12) |
| Apr 28, 2016 | John L Erb | Director | Sell | $356K (10,000 @ $35.58) |
| Apr 27, 2016 | Timothy Slayton | Principal Accounting Officer | Sell | $110K (2,994 @ $36.72) |
| Apr 27, 2016 | Howard Root | Chief Executive Officer | Sell | $562K (15,582 @ $36.07) |
| Feb 29, 2016 | Charmaine Sutton | Sr. VP Regulatory & QA | Sell | $432K (14,325 @ $30.13) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.